SG:42C Stock Latest News
Company AnnouncementsiX Biopharma details Wafermine milestones and U.S. compounding push ahead of AGM3w ago42C
Company AnnouncementsiX Biopharma Secures SGX Nod for Debt-for-Equity Share Listing3w ago42C
Company AnnouncementsiX Biopharma Moves to Convert A$1.7 Million Debt Into Equity4w ago42C
Company AnnouncementsiX Biopharma Rides DoD-Backed Wafermine Push and U.S. Expansion Strategy1M ago42C
Company AnnouncementsiX Biopharma Advances Wafermine as U.S. Opens Rare Military Emergency Use Pathway1M ago42C
Company AnnouncementsiX Biopharma Warrants See Strong Insider Take-Up, Funding U.S. Expansion3M ago42C
Company AnnouncementsiX Biopharma Sets Final Timetable for Expiry and Delisting of SGX-Listed Warrants3M ago42C
Company AnnouncementsiX Biopharma Sets July 2026 Expiry for S$0.06 Warrants4M ago42C
Company AnnouncementsiX Biopharma Shifts Production Gear to U.S. to Support Wafermine Contract and Growth Push4M ago42C
Company AnnouncementsiX Biopharma Shareholders Approve New Share Issues and CEO Performance Award5M ago42C
Company AnnouncementsiX Biopharma Restructures Consumer Arm and Advances U.S. Joint Venture Plans5M ago42CCompany AnnouncementsiX Biopharma Clarifies Time-Based Vesting of Performance Shares Ahead of EGM6M ago42C
Company AnnouncementsiX Biopharma Wins Conditional SGX Nod for New Share Placement6M ago42C
Company AnnouncementsiX Biopharma Wins US$41 Million U.S. Contract to Advance Wafermine Pain Therapy8M ago42C
Company AnnouncementsiX Biopharma Wins US$41 Million U.S. Defense Contract for Non-Opioid Pain Drug8M ago42C
Company AnnouncementsiX Biopharma to Raise At Least S$6 Million via Share Placement8M ago42CCompany AnnouncementsiX Biopharma Earns Third Spot on Singapore’s Fastest Growing Companies List9M ago42C
